Back to Compound Explorer

Umckalin (6,8-Dihydroxy-5,7-dimethoxycoumarin)

Strong

Mechanism of Action

Inhibits adhesion of bacterial pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) to human buccal and bronchial epithelial cells, preventing colonisation without direct bactericidal activity; induces type I and type II interferon production in monocytes and macrophages, activating innate antiviral immune response; inhibits neuraminidase activity of influenza A and B viruses, limiting viral particle release; exhibits mild anticoagulant activity via inhibition of vitamin K-dependent clotting factor synthesis.

Research Notes

Umckalin is identified as the principal anti-adhesive compound in EPs® 7630. In vitro studies confirm inhibition of multiple respiratory pathogen adhesion at clinically relevant concentrations. Interferon-inducing activity has been confirmed in human peripheral blood mononuclear cell models. Its contribution to the observed clinical effects in RCTs is considered central alongside polysaccharide immunomodulation.

Found In 1 Herb

3D Molecular Structure

Oxygenated coumarin
Drag to rotate · Click atoms to explore

Umckalin (6,8-Dihydroxy-5,7-dimethoxycoumarin)

Oxygenated coumarinBioactive phytochemical with therapeutic properties

Representative pattern: C₇H₆O₃

Atoms
Carbon
Oxygen
Hydrogen

Live Research

Open on PubMed

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.